Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis

Bruce A. Cohen

doi:10.1212/WNL.0000000000006924

Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis

Bruce A. Cohen^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Original language	English (US)
Pages (from-to)	435-436
Number of pages	2
Journal	Neurology
Volume	92
Issue number	9
DOIs	https://doi.org/10.1212/WNL.0000000000006924
State	Published - Feb 26 2019

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000006924

Cite this

@article{ba86bcd5363e4c239f2b0e15a07921b8,

title = "Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis",

author = "Cohen, {Bruce A.}",

year = "2019",

month = feb,

day = "26",

doi = "10.1212/WNL.0000000000006924",

language = "English (US)",

volume = "92",

pages = "435--436",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis

AU - Cohen, Bruce A.

PY - 2019/2/26

Y1 - 2019/2/26

UR - http://www.scopus.com/inward/record.url?scp=85062191049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062191049&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000006924

DO - 10.1212/WNL.0000000000006924

M3 - Article

C2 - 30635476

AN - SCOPUS:85062191049

SN - 0028-3878

VL - 92

SP - 435

EP - 436

JO - Neurology

JF - Neurology

IS - 9

ER -

Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this